Quidelortho Corpoation ($QDEL) Stock Forecast: Down 2.4% Today

What is Quidelortho Corpoation?

QuidelOrtho Corporation (QDEL) is a company specializing in diagnostic healthcare solutions, particularly known for its rapid testing products. The stock had a strong bearish movement today amidst market volatility.

Why is Quidelortho Corpoation going down?

QDEL stock is down 2.4% on Jul 1, 2024 15:00

• The release of an investor letter indicating moderate economic growth may have raised concerns about QDEL's growth prospects, leading to selling pressure.
• Entities selling over $4.9 million in QDEL shares could have signaled lack of confidence in the company's future performance, contributing to the bearish trend.
• Underperformance compared to the Russell 2000 Growth index and their decision to sell QDEL shares might have influenced other investors to follow suit, impacting the stock negatively.
• An investigation on behalf of long-term stockholders following a class action complaint could have created uncertainty and fear among investors, further driving down QDEL's stock price.

QDEL Price Chart

QDEL News

Should You Sell QuidelOrtho Corporation (QDEL)?

Chartwell Investment Partners, LLC, an affiliate of Carillon Tower Advisers, Inc., released the “Carillon Chartwell Small Cap Growth Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here. In the first quarter of 2024, the U.S. economy showed signs of moderate growth, with indications of an upturn towards the end of […]

https://www.insidermonkey.com/blog/should-you-sell-quidelortho-corporation-qdel-1318133/

Carlyle group entities sell over $4.9 million in QuidelOrtho shares

https://www.investing.com/news/company-news/carlyle-group-entities-sell-over-49-million-in-quidelortho-shares-93CH-3496592

https://www.investing.com/news/company-news/carlyle-group-entities-sell-over-49-million-in-quidelortho-shares-93CH-3496592

What Made The Brown Capital Management Small Company Fund to Sell QuidelOrtho Corporation (QDEL)?

Brown Capital Management, an investment management company, released its “The Brown Capital Management Small Company Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here. The Small Company Fund returned 0.48%, significantly underperforming the Russell 2000 Growth index’s 7.58% return. Following the release of the inflation report in February, the […]

https://www.insidermonkey.com/blog/what-made-the-brown-capital-management-small-company-fund-to-sell-quidelortho-corporation-qdel-1317692/

QUIDELORTHO ALERT: Bragar Eagel & Squire, P.C. is Investigating QuidelOrtho Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - QuidelOrtho ( NASDAQ:QDEL )

NEW YORK, June 24, 2024 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against QuidelOrtho Corporation QDEL on behalf of long-term stockholders following a class action complaint that was filed against ...

https://www.benzinga.com/pressreleases/24/06/g39470160/quidelortho-alert-bragar-eagel-squire-p-c-is-investigating-quidelortho-corporation-on-behalf-of-lo

Trending Today

ON Semiconductor Corporation ($ON) Stock Forecast: Up 0.4% Today

Floki ($FLOKI) Crypto Forecast: Down 7.5% Today

Reddit Inc ($RDDT) Stock Forecast: Up 5.6% Today

Rocket Companies Inc ($RKT) Stock Forecast: Up 5.1% Today

Polygon ($MATIC) Crypto Forecast: Down 5.1% Today

Nikola corporation ($NKLA) Stock Forecast: Down 6.3% Today

Worldcoin ($WLD) Crypto Forecast: Up 9.0% Today

Jupiter ($JUP) Crypto Forecast: Down 5.5% Today

Sirius XM Holdings Inc. ($SIRI) Stock Forecast: Up 15.3% Today

Tesla Inc. ($TSLA) Stock Forecast: Up 6.5% Today

Quidelortho Corpoation Price History

25.05.2024 - QDEL Stock was down 5.1%

• The selling of QuidelOrtho Corporation stock by the Brown Capital Management Small Company Fund could have contributed to the bearish movement, indicating a lack of confidence in the company's performance.
• An investigation on behalf of long-term stockholders might have raised concerns among investors, leading to a sell-off of QDEL shares.
• QuidelOrtho's stock took a hit due to disappointing guidance, as highlighted in an investor letter, signaling potential challenges ahead for the company's financial performance.

13.05.2024 - QDEL Stock was down 6.8%

• Quidel Corporation (QDEL) witnessed a notable downturn in its stock price today.
• Various legal firms have alerted investors about deadlines related to class action lawsuits against QDEL, which allege violations of securities laws.
• The uncertainties surrounding these legal matters and their potential financial consequences are likely influencing the negative movement in QDEL’s market performance.
• Investors may be responding to the imminent deadlines and ongoing legal inquiries, leading to increased selling pressure on QDEL shares.

15.04.2024 - QDEL Stock was up 6.3%

• QuidelOrtho (QDEL) saw a significant 5.4% increase in its stock price today, reportedly linked to activist investor Jana Partners acquiring a stake in the company.
• Despite facing legal issues, including a class action lawsuit connected to financial performance and management choices, investor sentiment seems to have improved following news of Jana Partners' investment.
• The positive market response may reflect growing confidence in QuidelOrtho's future prospects after Jana Partners' involvement, overshadowing legal challenges.
• This demonstrates how external influences, like substantial investments from recognized entities, can sometimes have a greater impact on a company's stock performance than negative legal developments.

14.04.2024 - QDEL Stock was up 7.3%

• Today's bullish movement in QDEL's stock price can be attributed to the following factors:
• Despite the ongoing class action lawsuits and legal challenges faced by the company, investors seem to be optimistic about QDEL's ability to navigate through the legal issues and maintain its market position.
• The market may have reacted positively to any recent developments or announcements from Quidel Corporation that instilled confidence in investors regarding the company's future performance and growth prospects.
• The resilience shown by QDEL in the face of legal uncertainties could have reassured investors about the company's operational strength and management's ability to steer through challenging times.
• The bullish sentiment surrounding QDEL could also be influenced by broader market trends or sector-specific factors that are favorably impacting healthcare and diagnostic testing companies.

10.04.2024 - QDEL Stock was down 5.2%

• QDEL's Q1 earnings beat estimates, but margins fell, indicating potential concerns about profitability.
• The company is facing lawsuits for securities law violations, which could be negatively impacting investor confidence.
• Shareholders being encouraged to contact The Gross Law Firm regarding their rights may have raised concerns about potential legal liabilities for the company.
• The challenges highlighted in the Q1 2024 earnings call transcript may have contributed to the bearish market movement as investors assess the company's ability to navigate these obstacles.

09.04.2024 - QDEL Stock was up 2.9%

• Despite missing EPS estimates, QuidelOrtho (QDEL) managed to beat revenue expectations for Q1 2024, showcasing strong financial performance.
• The positive earnings and revenue surprises of 2.33% and 1.96%, respectively, have likely contributed to the bullish movement in QDEL stock.
• The looming class action lawsuits against QuidelOrtho Corporation may have initially caused some uncertainty in the market, but the company's solid financial results have overshadowed these concerns, leading to the bullish trend.
• Investors seem to be reacting positively to the company's ability to navigate challenges with strategic optimism, as highlighted in the Q1 2024 Earnings Call Transcript.

09.04.2024 - QDEL Stock was up 2.9%

• QuidelOrtho reported Q1 2024 earnings with a miss on EPS but beat revenue expectations, showcasing strong financial performance.
• The appointment of a new CEO, Brian J. Blaser, signals positive changes and growth prospects for the company.
• Despite facing class action lawsuits and investor reminders, the market reacted positively to the company's financial results and future leadership, driving the bullish movement in the stock.

09.03.2024 - QDEL Stock was up 5.1%

• QuidelOrtho's stock saw a significant increase in value after securing FDA approval for their QuickVue COVID-19 testing product, demonstrating strong investor confidence in the company's offerings.
• Despite facing a securities class action investigation, the market response focused more on the positive FDA approval news, leading to a rise in the stock price and downplaying the legal issues.
• The stock price took an 11% hit following an update on the Savanna PVP4+ assay, but this decline was offset by the favorable FDA approval news, illustrating the market's volatility in reacting to various developments related to QuidelOrtho.

02.03.2024 - QDEL Stock was down 9.5%

• Despite obtaining FDA 510(k) clearance for its QuickVue COVID-19 test for home and medical facility use, QuidelOrtho's stock dropped by 11%.
• Potential reasons for this decline include concerns about competition in the COVID-19 testing sector and uncertainties regarding market acceptance of the test.
• The stock may have been impacted by investor disappointment in the update on the Savanna PVP4+ assay, leading to reduced confidence in the company's performance.
• Additionally, profit-taking by traders who previously purchased the stock in anticipation of positive developments may have contributed to the bearish movement.

02.03.2024 - QDEL Stock was down 10.1%

• The FDA clearance for QuidelOrtho's COVID-19 test for home use and the FDA 510(k) clearance for its QuickVue COVID-19 test should have been positive news for the company.
• However, the ongoing securities class action investigation regarding potential securities claims may have spooked investors, leading to the bearish movement in QDEL stock.
• The market may be reacting to uncertainties surrounding the investigation, overshadowing the positive developments in the company's COVID-19 testing products.

02.03.2024 - QDEL Stock was down 7.2%

• The FDA 510(k) clearance for QuidelOrtho's QuickVue COVID-19 test could have initially boosted investor confidence and expectations for the company's future performance.
• However, the ongoing securities class action investigation regarding potential claims against QuidelOrtho may have introduced uncertainty and negative sentiment among investors, leading to the bearish market movement.
• The combination of positive regulatory news and legal uncertainties likely created a volatile trading environment for QDEL, resulting in the significant downward movement in the stock price today.

22.01.2024 - QDEL Stock was down 5.1%

• QuidelOrtho experienced a notable downturn due to various negative factors, such as a year-over-year revenue decrease and downgrades from analysts.
• CEO Douglas Bryant's exit and subsequent leadership restructuring may have led to uncertainty and reduced investor confidence in the company's future direction.
• Ongoing legal probes by multiple firms looking into potential claims against QuidelOrtho may have added to the downward pressure on the stock.
• The collective impact of leadership changes, financial performance issues, and legal scrutiny likely contributed to the selling pressure on QuidelOrtho shares, resulting in a significant decline in the stock price.